|
|
| |
 |
Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1
Letter from Oct 9 N Engl J Med
|
|
|
Insights into inflammation and influenza
|
|
|
Pandemic Influenza
CIDRAP-authored overview, updated Oct 3 with new research
|
|
|
Influenza pandemic: HHS needs to continue its actions and finalize guidance for pharmaceutical interventions
GAO report released Sep 30
|
|
|
Public health emergency preparedness: six years of achievement
Sep 29 document from ASTHO, APHL, CSTE, and NACCHO
|
|
|
Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as human vaccines
WHO document updated Sep 29
|
|
|
Avian influenza A (H5N1) and pandemic influenza
State Department fact sheet updated Sep 27
|
|
|
H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 viruses
|
|
|
Pandemic influenza and excess intensive-care workload
From Emerg Infect Dis, published online Sep 25
|
|
|
Resource allocation during an influenza pandemic
Letter from Emerg Infect Dis, published online Sep 25
|
|
|
Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial
From J Infect Dis, published online Sep 22
|
|
|
Cross-protection between successive waves of the 1918-1919 influenza pandemic: epidemiological evidence from US Army camps and from Britain
From J Infect Dis, published online Sep 22
|
|
|
Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans
From Lancet Infect Dis, published online Sep 22
|
|
|
Preparing for the real storm during the calm: a comparison of the crisis preparation strategies for pandemic influenza in China and the US
From J Homeland Secur Emerg Manage, published online Sep 18
|
|
|
Corporate preparedness for pandemic influenza: a survey of pharmaceutical and biotechnology companies in Montgomery County, Maryland
From Biosecur Bioterr, published online Sep 17
|
|
|
Ethics and severe pandemic influenza: maintaining essential functions through a fair and considered response
From Biosecur Bioterr, published online Sep 17
|
|
|
Perceptions related to bird-to-human avian inlfuenza, influenza vaccination, and use of face mask
From Infection, published online Sep 15
|
|
|
Influenza vaccines: research, development and public health challenges
Special issue of Vaccine, published online Sep 12
|
|
|
Pathology of human influenza revisited
From special issue of Vaccine, published online Sep 12
|
|
|
Correlates of protection: novel generations of influenza vaccines
From special issue of Vaccine, published online Sep 12
|
|
|
US policy regarding pandemic-influenza vaccines
Report from Congressional Budget Office released Sep 15
|
|
|
Pandemic influenza: surge capacity and prioritisation in health services
Draft of UK Department of Health report, published Sep 4
|
|
|
Pandemic influenza in Australia: using telephone surveys to measure perceptions of threat and willingness to comply
From BMC Infect Dis, published online Sep 15
|
|
|
AHRQ Hospital Surge Model
Estimates hospital resources needed for disease or terror attack; released Sep 12
|
|
|
Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) (Prepandrix): a review of its use as an active immunization against influenza A subtype H5N1 virus
|
|
|
Evidence of expanded host range and mammalian-associated genetic changes in a duck H9N2 influenza virus following adaptation in quail and chickens
From PLoS ONE, published online Sep 9
|
|
|
September is National Preparedness Month
Home page for 2008 DHS readiness campaign
|
|
|
The next flu pandemic: what to expect
CDC fact sheet released in Aug
|
|
|
Plan now to be ready for the next flu pandemic
CDC fact sheet released in Aug
|
|
|
WHO: Confirmed Human Cases of Avian Influenza A (H5N1)
|
|
